In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 62, Issue 3, 2006, Pages 321-331

  Cheung, Richard Y ^a   Rauth, Andrew M ^b   Ronaldson, Patrick T ^a   Bendayan, Reina ^a   Wu, Xiao Yu ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Anticancer drug combinations; Breast cancer cells; Doxorubicin; Microspheres; Mitomycin C

Indexed keywords

DOXORUBICIN; MICROSPHERE; MITOMYCIN C;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL DENSITY; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG RELEASE; IN VITRO STUDY; MOUSE; NONHUMAN; UPREGULATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DOXORUBICIN; DRUG COMPOUNDING; DRUG SYNERGISM; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICROSPHERES; MITOMYCIN; P-GLYCOPROTEIN; UP-REGULATION;

EID: 33644828056     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.09.011     Document Type: Article

References (48)

1. M.J. Boyer, and I.F. Tannock Cellular and molecular basis of chemotherapy I.F. Tannock R.P. Hill The Basic Science of Oncology 1998 McGraw-Hill Toronto 350 369
2. I.F. Tannock, and G.J. Goldenberg Drug resistance and experimental chemotherapy I.F. Tannock R.P. Hill The Basic Science of Oncology 1998 McGraw-Hill Toronto 392 419
3. D.S. Fischer, M.T. Knobf, and H.J. Durivage Cancer chemotherapy and pharmacology The Cancer Chemotherapy Handbook 1997 Mosby Toronto pp. 1-20
4. R.K. Jain Barriers to drug delivery in solid tumors Sci. Am. 271 1994 58 65
5. M.J. Moore, and C. Erlichman Pharmacology of anticancer drugs I.F. Tannock R.P. Hill The Basic Science of Oncology 1998 McGraw-Hill Toronto 370 391
6. Adriamycin monograph, in: C. Repchinsky (Ed.), Compendium of Pharmaceuticals and Specialties, Canadian Pharmacists Association, Ottawa, 2003, pp. 36-37.
7. S.R. Keyes, D.C. Heimbrook, P.M. Fracasso, S. Rockwell, S.G. Sligar, and A.C. Sartorelli Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C Adv. Enzyme Regul. 23 1985 291 307
8. D. Glaubiger, and A. Ramu Antitumor antibiotics B. Chabner Pharmacologic Principles of Cancer Treatment 1982 W.B. Saunders Company Toronto 402 415
9. P.K. Gupta, C.T. Hung, and D.F.C. Lam Applications of particulate carriers A. Rolland Intratumoral Drug Delivery 1993 Marcel Dekker New York 135 164
10. N. Willmott Agents for microsphere incorporation: physicochemical considerations and physiological consequences of particle embolization N. Willmott J. Daly Microspheres and Regional Cancer Therapy 1994 CRC Press Boca Raton 117 139
11. M.J.M. Deurloo, S. Bohlken, W. Kop, C.F. Lerk, W. Hennick, H. Bartelink, and A.C. Begg Intratumoral administration of cisplatin in slow-release device. I. Tumor response and toxicity Cancer Chemother. Pharmacol. 27 1990 135 140
12. A. Hagiwara, C. Sakakura, M. Shirasu, J. Yamasaki, T. Togawa, T. Takahashi, S. Muranishi, S. Hyon, and Y. Ikada Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by colon 26 or B-16 melanoma in mice Anticancer Drugs 9 1998 287 289
13. Z. Liu, J.R. Ballinger, A.M. Rauth, R. Bendayan, and X.Y. Wu Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres J. Pharm. Pharmacol. 55 2003 1063 1073
14. Z. Liu, R. Cheung, X.Y. Wu, J.R. Ballinger, R. Bendayan, and A.M. Rauth A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres J. Control. Release 77 2001 213 224
15. Z. Liu, X.Y. Wu, and R. Bendayan In vitro investigation of ionic polysaccharide microspheres for simultaneous delivery of chemosensitizer and antineoplastic agent to multidrug-resistant cells J. Pharm. Sci. 88 1999 412 418
16. Z. Liu, In vitro and in vivo studies of microspheres for locoregional delivery of chemosensitizing and antineoplastic agents, PhD Dissertation, University of Toronto, Toronto, 2000.
17. A.M. Rauth, J.K. Mohindra, and I.F. Tannock Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo Cancer Res. 43 1983 4154 4158
18. I.F. Tannock Response of aerobic and hypoxic cells in a solid tumor to Adriamycin and cyclophosphamide and interaction of the drugs with radiation Cancer Res. 42 1982 4921 4926
19. S. Rockwell Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo J. Natl Cancer Inst. 71 1983 765 771
20. R.Y. Cheung, Y. Ying, A.M. Rauth, N. Marcon, and X.Y. Wu Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C Biomaterials 26 2005 5375 5385
21. R.Y. Cheung, A.M. Rauth, and X.Y. Wu In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations Anticancer Drugs 16 2005 423 433
22. M.A. Shah, and G.K. Schwartz Cell cycle-mediated drug resistance: an emerging concept in cancer therapy Clin. Cancer Res. 7 2001 2168 2181
23. J.W. Adlard, and D.J. Dodwell Optimum anthracycline-based chemotherapy for early breast cancer Lancet Oncol. 2 2001 469 474
24. J.K. Tunggal, J.R. Ballinger, and I.F. Tannock Influence of cell concentration in limiting the therapeutic benefit of p-glycoprotein reversal agents Int. J. Cancer 81 1999 741 747
25. J.K. Tunggal, D.S.M. Cowan, H. Shaikh, and I.F. Tannock Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors Clin. Cancer Res. 5 1999 1583 1586
26. P.R. Twentyman, T. Rhodes, and S. Rayner A comparison of rhodamine 123 accumulation and efflux in cells with p-glycoprotein-mediated and mrp-associated multidrug resistance phenotypes Eur. J. Cancer 30A 1994 1360 1369
27. M.A. Ihnat, J.P. Lariviere, A.J. Warren, N. La Ronde, J.R. Blaxall, K.M. Pierre, B.W. Turpie, and J.W. Hamilton Suppression of p-glycoprotein expression and multidrug resistance by DNA cross-linking agents Clin. Cancer Res. 3 1997 1339 1346
28. R.G. Bristow, and R.P. Hill Molecular and cellular basis of radiotherapy I.F. Tannock R.P. Hill The Basic Science of Oncology 1998 McGraw-Hill Toronto 295 321
29. P.T. Ronaldson, M. Bendayan, D. Gingras, M. Piquette-Miller, and R. Bendayan Cellular localization and functional expression of p-glycoprotein in rat astrocyte cultures J. Neurochem. 89 2004 788 800
30. G.G. Steel, and M.J. Peckham Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity Int. J. Radiat. Oncol. Biol. Phys. 5 1979 85 91
31. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeablility in Chinese hamster ovary cell mutants Biochim. Biophys. Acta 455 1976 152 162
32. E. Georges, G. Bradley, J. Gariepy, and V. Ling Detection of p-glycoprotein isoforms by gene-specific monoclonal antibodies Proc. Natl Acad. Sci. USA 87 1990 152 156
33. R.C. Mehta, T.F. Hogan, S. Mardmomen, and J.K. Ma Chromatographic studies of mitomycin C degradation in albumin microspheres J. Chromatogr. 430 1988 341 349
34. H. Natsume, K. Sugibayashi, and Y. Morimoto In vitro release profile of mitomycin C from albumin microspheres: extrapolation from macrospheres to microspheres Pharm. Res. 8 1991 185 190
35. J. Cummings, L. Allan, and J.F. Smyth Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumor activity. Implications for the drugs' in vivo mechanism of action Biochem. Pharmacol. 47 1994 1345 1356
36. A. Begleiter, and M.K. Leith Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin c in vitro Biochem. Pharmacol. 50 1995 1281 1286
37. E. Dikomey, I. Brammer, J. Johansen, S.M. Bentzen, and J. Overgaard Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients Int. J. Radiat. Oncol. Biol. Phys. 46 2000 481 490
38. M.A. Ihnat, A.M. Nervi, S.P. Anthony, R.C. Kaltreider, A.J. Warren, C.A. Pesce, S.A. Davis, J.P. Lariviere, and J.W. Hamilton Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated p-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice Oncol. Res. 11 1999 303 310
39. R. Maitra, P.A. Halpin, K.H. Karlson, R.L. Page, D.Y. Paik, M.O. Leavitt, B.D. Moyer, B.A. Stanton, and J.W. Hamilton Differential effects of mitomycin C and doxorubicin on p-glycoprotein expression Biochem. J. 255 2001 617 624
40. T. Litman, T.E. Druley, W.D. Stein, and S.E. Bates From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Cell. Mol. Life Sci. 58 2001 931 959
41. E. Okochi, T. Iwashashi, and T. Tsuruo Monoclonal antibodies specific for p-glycoprotein Leukemia 11 1997 1119 1123
42. P.R. Twentyman, J.G. Reeve, G. Koch, and K.A. Wright Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of p-glycoprotein and CP22 (sorcin) Br. J. Cancer 62 1990 89 95
43. S.H. Chambers, N.M. Bleehan, and J.V. Watson Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells Br. J. Cancer 49 1999 301 306
44. S. Rockwell, and C.G. Irvin Interaction of radiation and mitomycin C treatments in vitro Radiat. Res. 87 1981 437
45. S. Rockwell Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro Int. J. Cancer 38 1986 229 235
46. S. Rockwell, and C.S. Hughes Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures Cell Prolif. 27 1994 153 163
47. M. Andersson, S. Daugaard, H. Von Der Maase, and H.T. Mouridsen Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study Cancer Treat. Rep. 70 1986 1181 1186
48. G.N. Hortobagyi Mitomycin: its evolving role in the treatment of breast cancer Oncology 50 Suppl. 1993 1 8